BLGO 10-Q: SEC filing

BioLargo, Inc.

Filed with the SEC on · accession 0001437749-26-037232

BLGO filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.

Summary of the filing

BioLargo, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results including revenue, expenses, and segment information for its subsidiaries.

Key details

FilerBioLargo, Inc.
SubsidiaryClyra Medical Technologies
SubsidiaryBioLargo Energy Technologies Inc. (BETI)
SubsidiaryBioLargo Consumer Products Group (BCPG)

✦ Ask GOAX AI about this filing — what it means for BLGO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for BLGO?

Click here

Frequently asked questions

What did BLGO file with the SEC on Nov 16, 2026?

BLGO filed a 10-Q (SEC filing). BioLargo, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting routine financial results including revenue, expenses, and segment information for its subsidiaries.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

Other BLGO SEC filings

Get alerts when BLGO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days